Erythropoietin and Pro-Inflammatory Cytokines Levels in Dogs with Mammary Carcinoma
World Small Animal Veterinary Association World Congress Proceedings, 2015
S. Borin-Crivellenti1; L.Z. Crivellenti2; D.G. Silva1; M. Tinucci-Costa1; A.E. Santana1
1Departament of Veterinary Clinic and Surgery, São Paulo State University (UNESP) Jaboticabal, Jaboticabal, Brazil; 2Departament of Veterinary Clinic and Surgery, Universidade de Franca (UNIFRAN), Franca, Brazil

Recently, it has been demonstrated that erythropoietin (EPO) and its receptor are expressed in advanced solid tumor, and could be involved in human breast carcinoma growth. Pro-inflammatory cytokines TNF-α, IFN-γ and IL-1β are released in elevated inflammatory response and neo-vascularization tumor areas, and present remarkable synergism in human cell lines carcinomas. The aim of our study was to evaluate circulating concentrations of EPO, IL-1β, TNF-α and IFN-γ in dogs (n = 10) with histological diagnosis of mammary gland carcinoma and without evidence of metastasis. Ten aged-matched intact bitches served as control group (CG).

Sandwich enzyme immunoassays for the quantitative measurement for canine serum were used to quantify EPO and the cytokines (USCN Life Science Inc., China). Continuous variables were evaluated for normality followed by Tukey's post-hoc test, and differences were considered significant at p < 0.05.

Erythropoietin concentrations was higher in dogs with mammary carcinoma (4.42 ± 0.63 U/L) than healthy dogs (1.88 ± 0.33 U/L, p = 0.014). No significant difference was observed in IFN-γ and IL-1b between groups, but TNF-α concentration was higher in dogs with mammary carcinoma compared to CG (26.68 ± 3.43; 10.48 ± 2.61 pg/mL, respectively; p = 0.0043).

The most well-recognized alteration in pro-inflammatory cytokines is seen in human advanced carcinomas. In our study, we selected dogs to accesses the earliest possible inflammatory alterations associated with mammary carcinoma. In view of these data, we observed that EPO and TNF-α were already increased in early stages of canine mammary carcinoma, showing that even early stages were able to change homeostasis of the immune system, inflammation and host defense.

  

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

S. Borin-Crivellenti
Department of Veterinary Clinic and Surgery
São Paulo State University (UNESP)-Jaboticabal
Jaboticabal, Brazil


MAIN : Oncology : Erythropoietin & Pro-Inflammatory Cytokines Levels
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.

CONTACT US

777 W. Covell Blvd., Davis, CA 95616

vingram@vin.com

PHONE

  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357
SAID=27